Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 20, 2021 - Issue 4
Submit an article Journal homepage
397
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Comparing the use of individual and composite terms to evaluate adverse drug event disproportionality: a focus on glucagon-like peptide-1 receptor agonists and diabetic retinopathy

Daniel G. DaunerDepartment of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, MN, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1198-0468View further author information
ORCID Icon &
Joel F. FarleyDepartment of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, MN, USAORCID Iconhttps://orcid.org/0000-0002-5196-5238View further author information
ORCID Icon
Pages 475-480 | Received 23 Sep 2020, Accepted 04 Feb 2021, Published online: 26 Mar 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Daniel G. Dauner, Rui Zhang, Terrence J. Adam, Eleazar Leal, Viviene Heitlage & Joel F. Farley. (2023) Performance of subgrouped proportional reporting ratios in the US Food and Drug Administration (FDA) adverse event reporting system. Expert Opinion on Drug Safety 22:7, pages 589-597.
Read now

Articles from other publishers (4)

Yong-Chen Wang, Lu Wang, Yu-Qi Shao, Shi-Jun Weng, Xiong-Li Yang & Yong-Mei Zhong. (2023) Exendin-4 promotes retinal ganglion cell survival and function by inhibiting calcium channels in experimental diabetes. iScience 26:9, pages 107680.
Crossref
Zheng Yang, Meng Yu, Mei Mei, Chongxin Chen, Yuhuan Lv, Linyu Xiang & Rong Li. (2022) The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting system. Nutrition, Metabolism and Cardiovascular Diseases 32:2, pages 504-510.
Crossref
Etelka Pöstyéni, Alma Ganczer, Andrea Kovács-Valasek & Robert Gabriel. (2022) Relevance of Peptide Homeostasis in Metabolic Retinal Degenerative Disorders: Curative Potential in Genetically Modified Mice. Frontiers in Pharmacology 12.
Crossref
Feiyu Wang, Yinjun Mao, Hang Wang, Yiwei Liu & Pinfang Huang. (2021) Semaglutide and Diabetic Retinopathy Risk in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. Clinical Drug Investigation 42:1, pages 17-28.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.